Catalogue of Cancer Genes – The First Step to Winning the Fight against Cancer
DOI:
https://doi.org/10.61841/571hpx50Keywords:
Sequencing, Cancer, Proto-oncogene, Anti-oncogene, Cancer Genome AtlasAbstract
Performance of an important task of creating a detailed catalogue of cancer genes will allow us to select an optimal cancer therapy for each patient. To catalog cancer genes mutating with high (>20%) and medium (2–20%) frequency, 200 “tumor-norm” pairs on average for each gene should be analyzed, i.e., about 100,000 pairs for the most common types of cancer. Nowadays, the problem is no longer insoluble, since the cost of DNA sequencing has decreased a millionfold over the last 10 years and will continue to decrease more.
Downloads
References
[1] Bamford S., Dawson E., Forbes S. et al. The COSMIC (Catalogue of Somatic Mutations in Cancer)
British Journal of Cancer—2004—19 July (vol. 91, no. 2). - Pp. 355-358.
[2] Boorjian S., Cowan J.E., Konety B.R., et al. Cancer of the Prostate Strategic Urologic Research Endeavor
Investigators. Bladder cancer incidence and risk factors in men with prostate cancer: results from Cancer of
the Prostate Strategic Urologic Research Endeavor // J Urol. 2007. Vol. Vol.177, № 3. Pp. 883-887.
[3] Chen M., Liang J., Ji H. et al. Cdk8/19 Mediator Kinases Potentiate Induction of Transcription by
Nfkappab // Proc. Natl. Acad. Sci. USA. 2017. V.114. N.38. Pp. 10208–10213.
[4] Chrouser K., Leibovich B. et al. Bladder cancer risk following primary and adjuvant external beam
radiation for prostate cancer // J. Urol. 2006. Vol. 174, № 1. Pp. 107-110.
[5] Creighton C.J., Morgan M., Gunaratne P.H. et al. The Cancer Genome Atlas Research Network.
Comprehensive molecular characterization of clear cell renal cell carcinoma // Nature. - 2013. - V.499. -
P.43-9.
[6] Duell E.J., Wiencke J.K., Cheng T.J., et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2
and biomarkers of DNA damage in human blood mononuclear cells // Carcinogenesis. 2000. Vol. 21, № 5.
P.965-71.
[7] Garnett M.J., Edelman E.J., Heidorn S.J., et al. Systematic identification of genomic markers of drug
sensitivity in cancer cells.// Nature. - 2012. - 28 March (vol. 483, no. 7391). - Pp. 570-575.
[8] Hakimi A.A., Ostrovnaya I., Reva B., et al. Adverse outcomes in clear cell renal cell carcinoma with
mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA
research network // Clin. Cancer Res. - 2013. - V.19. - I.12. Pp. 3259-67.
[9] Liang J., Chen M., Hughes D., et al. Cdk8 Selectively Promotes the Growth of Colon Cancer Metastases in
the Liver by Regulating Gene Expression of Timp3 and Matrix Metalloproteinases // Cancer Res. 2018.
V.78. N.23. Pp. 6594-6606.
[10] Li Ding & Michael C. Wendl. Differences that matter in cancer genomics // Nat Biotechnol. 2013. V.31.
Pp. 892-893.
[11] Marcin Imielinski et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing
// Cell. 2012. V.150. Pp. 1107-1120.
[12] McDermott M.S., Chumanevich A.A., Lim C.U., et al. Inhibition of CDK8 mediator kinase suppresses
oestrogen-dependent transcription and the growth of oestrogen receptor positive breast cancer // Oncotarget
2017. V.8 (8) Pp.12558-12570.
[13] Michael S. Lawrence et al., Mutational heterogeneity in cancer and the search for new cancer-associated
genes// Nature. 2013. V. 499. Pp. 214-218.
[14] Michael S. Lawrence et al. Discovery and saturation analysis of cancer genes across 21 tumour types //
Nature. 2014. V. 505. Pp. 495-501.
[15] Moullan N., Cox D.G., Angele S., Romestaing P., Gerard J.-P., Hall J. Polymorphisms in the DNA repair
gene XRCC1, breast cancer risk and response to radiotherapy // Cancer epidemiology, biomarkers &
prevention. 2003. Vol. 12. Pp. 1168.
[16] Park J.Y., Lee S.Y., Jeon H.-S. et al. Polymorphism of the DNA repair gene XRCC1 and risk of primary
lung cancer // Cancer epidemiology, biomarkers & prevention. 2002. Vol. 11. Pp. 23-27.
[17] Porter D. C., Farmaki E., Altilia S., et al. Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities // Proc. Natl. Acad. Sci. USA. 2012. V. 109. N. 34. Pp. 13799-13804.
[18] Roninson I. Seeking favors from nature // Journal Cancer Biology & Therapy. 2005. V.4. N.7. Pp. 794-799.
[19] Shen M., Hung R.J., Brennan P. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD interaction with environmental exposures and bladder cancer risk in a case-control study in Northern Italy //Cancer epidemiology, biomarkers & prevention. 2003. Vol. 12. Pp. 1234-1240.
[20] van Haaften G., Dalgliesh G.L., Davies H., et al. Somatic mutations of the histone H3K27 demethylase
gene UTX in human cancer./ Nature Genetics. - 2009.- May (vol. 41, no. 5). - Pp. 521-523.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
